Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections
RecruitingHealthy volunteers welcome
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Active Duty and DoD Beneficiaries (i.e. former military, spouse, dependent child) aged 18 years and older who work in the Mike O'Callaghan Military Medical Center at Nellis Air Force Base. Exclusion Criteria: * Unable to comfortably insert RD-X19 into the mouth and keep in place for 5 minutes * Plans for head, neck or mouth surgery during the study period * Plans for major dental procedures (ie implants, wisdom teeth extraction etc) during the study
About the study
The purpose of trial is to determine if daily usage of a photobiomodulation device will decrease the incidence of upper respiratory tract infections (URI) due to COVID, influenza or other viruses.The RD-X10 device is handheld, can be self-administered, and has been shown to be safe in invivo studies.
What is being tested
- RD-X19 (device)
- RD-X19 Sham (device)
Sponsor: David Moss · Participants: 130 · Started: Oct 1, 2026
Contact the study team
- Sandra Huffman · Phone: 7026533583
Official record on ClinicalTrials.gov — NCT07610967
Locations in the U.S.
| Nevada | Mike O'Callaghan Military Medical Center, Nellis Air Force Base |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.